Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SweatStop is a line of over-the-counter (OTC) topical antiperspirants developed by Alto Pharmaceuticals for the treatment of hyperhidrosis, particularly axillary hyperhidrosis. The product line contains varying strengths of aluminum chloride as the active ingredient, which works by forming temporary plugs in the sweat ducts to reduce perspiration. Available in various formats such as roll-ons, sprays, and lotions, SweatStop formulations often include skin-caring ingredients like Aloe Vera and provitamin B5 to minimize irritation. It is applied directly to the skin in affected areas to prevent excessive sweating and eliminate associated odors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SweatStop.